v3.26.3
Segment Information - Summary of Operating Result Information for Each Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue        
Revenue $ 24,923 $ 19,906 $ 68,010 $ 56,978
Cost of goods sold        
Cost of goods sold 3,503 2,709 8,237 8,100
Gross profit        
Gross profit 21,420 17,197 59,773 48,878
Operating expenses (27,548) (25,102) (82,201) (82,308)
Investment income 692 965 2,111 3,139
Interest expense (1,312) (1,306) (3,869) (3,853)
Other expense, net (51) (2) 1 (118)
Loss before income taxes (6,799) (8,248) (24,185) (34,262)
Interventional Glaucoma        
Revenue        
Revenue 21,046 19,718 60,105 56,063
Cost of goods sold        
Cost of goods sold 2,688 2,592 7,865 7,662
Gross profit        
Gross profit 18,358 17,126 53,471 48,401
Interventional Glaucoma tariff recovery        
Cost of goods sold        
Cost of goods sold (0) 0 (1,231) 0
Interventional Dry Eye        
Revenue        
Revenue 3,877 188 7,905 915
Cost of goods sold        
Cost of goods sold 815 117 1,738 438
Gross profit        
Gross profit 3,062 71 6,302 477
Interventional Dry Eye tariff recovery        
Cost of goods sold        
Cost of goods sold $ 0 $ 0 $ (135) $ 0